The application relates to compounds of formula (I) that show great affinity and activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the noradrenaline transporter (NET). The application also relates to processes for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments. The compounds are suitable for the treatment of pain and pain-related disorders.
                            该申请涉及化合物(I)的公式,这些化合物对于电压门控
钙离子通道(VGCC)的亚单位α2δ表现出很强的亲和力和活性,特别是对于电压门控
钙离子通道的α2δ-1亚单位或者对于电压门控
钙离子通道(VGCC)的亚单位α2δ表现出双重活性,特别是对于电压门控
钙离子通道的α2δ-1亚单位,以及
去甲肾上腺素转运体(NET)。该申请还涉及制备所述化合物的方法,以及包含它们的组合物,以及它们作为药物的用途。这些化合物适用于治疗疼痛和与疼痛相关的疾病。